全文获取类型
收费全文 | 22458篇 |
免费 | 3451篇 |
国内免费 | 1129篇 |
专业分类
耳鼻咽喉 | 167篇 |
儿科学 | 381篇 |
妇产科学 | 257篇 |
基础医学 | 4394篇 |
口腔科学 | 549篇 |
临床医学 | 1973篇 |
内科学 | 5097篇 |
皮肤病学 | 621篇 |
神经病学 | 1431篇 |
特种医学 | 514篇 |
外国民族医学 | 13篇 |
外科学 | 1855篇 |
综合类 | 2995篇 |
现状与发展 | 5篇 |
预防医学 | 1106篇 |
眼科学 | 357篇 |
药学 | 1745篇 |
4篇 | |
中国医学 | 289篇 |
肿瘤学 | 3285篇 |
出版年
2024年 | 23篇 |
2023年 | 435篇 |
2022年 | 536篇 |
2021年 | 1182篇 |
2020年 | 1135篇 |
2019年 | 1207篇 |
2018年 | 1121篇 |
2017年 | 1043篇 |
2016年 | 1156篇 |
2015年 | 1231篇 |
2014年 | 1516篇 |
2013年 | 1498篇 |
2012年 | 1519篇 |
2011年 | 1623篇 |
2010年 | 1425篇 |
2009年 | 1340篇 |
2008年 | 1288篇 |
2007年 | 1137篇 |
2006年 | 1003篇 |
2005年 | 818篇 |
2004年 | 626篇 |
2003年 | 657篇 |
2002年 | 512篇 |
2001年 | 481篇 |
2000年 | 401篇 |
1999年 | 279篇 |
1998年 | 220篇 |
1997年 | 204篇 |
1996年 | 127篇 |
1995年 | 129篇 |
1994年 | 129篇 |
1993年 | 106篇 |
1992年 | 100篇 |
1991年 | 68篇 |
1990年 | 60篇 |
1989年 | 59篇 |
1988年 | 62篇 |
1987年 | 44篇 |
1986年 | 46篇 |
1985年 | 83篇 |
1984年 | 58篇 |
1983年 | 46篇 |
1982年 | 33篇 |
1981年 | 45篇 |
1980年 | 51篇 |
1979年 | 27篇 |
1978年 | 36篇 |
1977年 | 18篇 |
1976年 | 31篇 |
1975年 | 16篇 |
排序方式: 共有10000条查询结果,搜索用时 218 毫秒
21.
22.
目的:研究Survivin-shRNA对视网膜母细胞瘤HXO-RB44细胞自噬及凋亡的影响。方法:培养视网膜母细胞瘤HXO-RB44细胞,构建Survivin-shRNA载体。按照处理不同分为Survivin-shRNA组、GFP组和CON组。分别采用流式细胞术检测Survivin-shRNA对HXO-RB44细胞凋亡和细胞周期的影响,应用MTT法检测Survivin-shRNA对HXO-RB44细胞活性的影响,Western blot法检测Survivin-shRNA对HXO-RB44 细胞自噬相关蛋白LC3、p62 与mTOR 表达的影响。结果:流式细胞术结果表明,与Control组和GFP组相比,Survivin-shRNA组细胞凋亡率增加,差异有统计学意义(P<0.05);随着作用时间的延长,S期出现阻滞,48 h阻滞最强,显著高于对照组(P<0.05)。MTT结果发现Survivin-shRNA可抑制HXO-RB44细胞增殖活性,与Control组和GFP组相比,差异有统计学意义(P<0.05);Western blot结果发现,与对照组相比,LC3表达量显著增加(P<0.01);而mTOR表达量降低(P<0.01)。结论:Survivin-shRNA可促进视网膜母细胞瘤HXO-RB44细胞的凋亡和自噬水平,进而特异性杀伤肿瘤细胞。 相似文献
23.
Natasa Strbo Irena Pastar Laura Romero Vivien Chen Milos Vujanac Andrew P. Sawaya Ivan Jozic Andrea D. F. Ferreira Lulu L. Wong Cheyanne Head Olivera Stojadinovic Denisse Garcia Katelyn O'Neill Stefan Drakulich Seth Taller Robert S. Kirsner Marjana Tomic‐Canic 《Experimental dermatology》2019,28(3):225-232
24.
25.
26.
27.
XiaoMin Wan PhD Xia Luo MS ChongQing Tan PhD XiaoHui Zeng PhD YuCong Zhang BS LiuBao Peng BS 《Cancer》2019,125(20):3526-3534
28.
《Journal of pharmaceutical sciences》2019,108(8):2661-2667
In order to evaluate the in vivo effect of inhaled formulations, it is a gold standard to create a lung metastasis model by intravenously injecting cancer cells into an animal. Because the cancer grows from the blood vessel side, there is a possibility of underestimating the effect of an inhaled formulation administered to the lung epithelium side. In addition, the metastasis model has disadvantages in terms of preparation time and expense. The present study aimed to establish a new method to evaluate the effect of an inhaled small interfering RNA (siRNA) formulation that is more correct, more rapid, and less expensive. We investigated whether siRNA can suppress gene expression of plasmid DNA (pDNA) by serial pulmonary administration of siRNA and pDNA powders prepared by spray-freeze-drying. We revealed that formulations of dry siRNA powder significantly suppressed gene expression of pDNA powder compared with a control group with no siRNA. Naked siRNA inhalation powder with no vector showed the suppression of gene expression equivalent to that of an siRNA-polyethyleneimine complex without damaging tissues. These results show that the present method is suitable for evaluating the gene-silencing effect of inhaled siRNA powders. 相似文献
29.
Hui Fan Xianzhen Jin Chunyan Liao Lina Qiao Wei Zhao 《Pathology, research and practice》2019,215(11):152667
MicroRNAs (miRNAs) have been found to be aberrantly expressed and exert essential roles in the tumorigenesis and progression of gastric cancer (GC). miR-301b-3p has been recognized as a cancer-related miRNA in lung cancer, bladder cancer and hepatocellular carcinoma. However, the function of miR-301b-3p in GC progression and its underlying mechanism have not been studied yet. In this study, we found that miR-301b-3p expression was up-regulated in GC tissues compared to adjacent noncancerous tissues. Furthermore, the elevated levels of miR-301b-3p were detected in GC cell lines (SGC-7901, AGS, MKN-45 and MGC-803) as compared with GES-1 cells. Interestingly, GC tissues from patients with tumor size ≥ 5 cm and advanced tumor stages showed obvious higher levels of miR-301b-3p compared to matched controls. Functionally, miR-301b-3p knockdown prominently inhibited cell proliferation, and induced cell cycle arrest at G1 phase and apoptosis in MGC-803 cells. Meanwhile, ectopic expression of miR-301b-3p conversely regulated these biological behaviors of MKN-45 cells. Next, we found that miR-301b-3p knockdown increased, whereas miR-301b-3p overexpression reduced the expression of zinc finger and BTB domain containing 4 (ZBTB4) in GC cells. Accordingly, luciferase reporter assay identified ZBTB4 as a direct target of miR-301b-3p. ZBTB4 overexpression markedly restrained the growth of MGC-803 cells. More importantly, ZBTB4 silencing partially reversed miR-301b-3p knockdown-induced tumor suppressive effects on MGC-803 cells. In conclusion, we firstly revealed that miR-301-3p was highly expressed in GC and contributed to tumor progression via attenuating ZBTB4, which might provide a novel molecular-targeted strategy for GC treatment. 相似文献
30.
Xinran Wang Ying Jia Huiyan Deng Yao Liu Yueping Liu 《Pathology, research and practice》2019,215(2):308-314
Recent studies have shown that intratumoral heterogeneity is prevalent in esophageal squamous cell cancer (ESCC) based on DNA sequencing and chromosome analysis in multiple regions from the same tumor. This study aimed to investigate the expression of ZNF750, EP300, MTOR and KMT2D and their intratumoral heterogeneity (ITH) in patients with ESCC. A total of 106 cases, who underwent esophagectomy from 2008 to 2010, with two foci from each case, were tested by immunohistochemistry(IHC) as well as 12 cases were tested by RNAscope in this study.We found that 58/106 (54.72%), 66/106 (62.26%), 75/106 (70.75%%) of ESCC showed high expression of ZNF750, EP300, MTOR, respectively by IHC, and 8/12 (66.67%), 10/12 (83.33%), 4/12 (33.33%) and 6/12 (50%) showed high expression of ZNF750, EP300, MTOR and KMT2D, respectively by RNAscope. Multivariate analysis showed that MTOR expression was an independent infavorable prognostic factor of overall survival (OS) (HR?=?1.921; P?=?0.000). This study also found that 44/106(4151%), 37/106 (34.91%), 39/106(36.79%) of ESCC showed heterogeneous expression of ZNF750, EP300 and MTOR respectively by IHC, 8/12(66.67%), 8/12(66.67%), 4/12(33.33%), 4/12(33.33%) of ZNF750, EP300, MTOR and KMT2D respectively by RNAscope, IHC and RNAscope could successfully detect a high prevalence of ITH. In conclusion, findings of this study showed that ZNF750, EP300, MTOR and KMT2D heterogeneously expressed in ESCC. High expression of ZNF750 related to a better outcome, while EP300 and MTOR related to a poor prognosis. 相似文献